266 related articles for article (PubMed ID: 20112374)
1. Nonsteroidal antiinflammatory drugs and prostaglandin E(2) modulate the synthesis of osteoprotegerin and RANKL in the cartilage of patients with severe knee osteoarthritis.
Moreno-Rubio J; Herrero-Beaumont G; Tardio L; Alvarez-Soria MA; Largo R
Arthritis Rheum; 2010 Feb; 62(2):478-88. PubMed ID: 20112374
[TBL] [Abstract][Full Text] [Related]
2. Long-term NSAID treatment directly decreases COX-2 and mPGES-1 production in the articular cartilage of patients with osteoarthritis.
Alvarez-Soria MA; Herrero-Beaumont G; Moreno-Rubio J; Calvo E; Santillana J; Egido J; Largo R
Osteoarthritis Cartilage; 2008 Dec; 16(12):1484-93. PubMed ID: 18547825
[TBL] [Abstract][Full Text] [Related]
3. Prevention of cartilage destruction with intraarticular osteoclastogenesis inhibitory factor/osteoprotegerin in a murine model of osteoarthritis.
Shimizu S; Asou Y; Itoh S; Chung UI; Kawaguchi H; Shinomiya K; Muneta T
Arthritis Rheum; 2007 Oct; 56(10):3358-65. PubMed ID: 17907189
[TBL] [Abstract][Full Text] [Related]
4. Aceclofenac increases the synthesis of interleukin 1 receptor antagonist and decreases the production of nitric oxide in human articular chondrocytes.
Maneiro E; López-Armada MJ; Fernández-Sueiro JL; Lema B; Galdo F; Blanco FJ
J Rheumatol; 2001 Dec; 28(12):2692-9. PubMed ID: 11764219
[TBL] [Abstract][Full Text] [Related]
5. The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells.
Kwan Tat S; Pelletier JP; Lajeunesse D; Fahmi H; Lavigne M; Martel-Pelletier J
Clin Exp Rheumatol; 2008; 26(2):295-304. PubMed ID: 18565252
[TBL] [Abstract][Full Text] [Related]
6. Histamine contributes to increased RANKL to osteoprotegerin ratio through altered nuclear receptor 4A activity in human chondrocytes.
Marzaioli V; McMorrow JP; Angerer H; Gilmore A; Crean D; Zocco D; Rooney P; Veale D; Fearon U; Gogarty M; McEvoy AN; Stradner MH; Murphy EP
Arthritis Rheum; 2012 Oct; 64(10):3290-301. PubMed ID: 22674155
[TBL] [Abstract][Full Text] [Related]
7. OPG/membranous--RANKL complex is internalized via the clathrin pathway before a lysosomal and a proteasomal degradation.
Tat SK; Padrines M; Theoleyre S; Couillaud-Battaglia S; Heymann D; Redini F; Fortun Y
Bone; 2006 Oct; 39(4):706-15. PubMed ID: 16750945
[TBL] [Abstract][Full Text] [Related]
8. Effect of IL-1beta, PGE(2), and TGF-beta1 on the expression of OPG and RANKL in normal and osteoporotic primary human osteoblasts.
Jurado S; Garcia-Giralt N; Díez-Pérez A; Esbrit P; Yoskovitz G; Agueda L; Urreizti R; Pérez-Edo L; Saló G; Mellibovsky L; Balcells S; Grinberg D; Nogués X
J Cell Biochem; 2010 May; 110(2):304-10. PubMed ID: 20225238
[TBL] [Abstract][Full Text] [Related]
9. Strontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblasts.
Tat SK; Pelletier JP; Mineau F; Caron J; Martel-Pelletier J
Bone; 2011 Sep; 49(3):559-67. PubMed ID: 21700005
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants.
Hardy MM; Seibert K; Manning PT; Currie MG; Woerner BM; Edwards D; Koki A; Tripp CS
Arthritis Rheum; 2002 Jul; 46(7):1789-803. PubMed ID: 12124863
[TBL] [Abstract][Full Text] [Related]
11. In vitro expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in cultured equine articular cells.
Byron CR; Barger AM; Stewart AA; Pondenis HC; Fan TM
Am J Vet Res; 2010 Jun; 71(6):615-22. PubMed ID: 20513175
[TBL] [Abstract][Full Text] [Related]
12. Bradykinin potentiates cytokine-induced prostaglandin biosynthesis in osteoblasts by enhanced expression of cyclooxygenase 2, resulting in increased RANKL expression.
Brechter AB; Lerner UH
Arthritis Rheum; 2007 Mar; 56(3):910-23. PubMed ID: 17328065
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the expression of 5-lipoxygenase-activating protein/5-lipoxygenase and the synthesis of leukotriene B(4) in osteoarthritic chondrocytes: role of transforming growth factor beta and eicosanoids.
Martel-Pelletier J; Mineau F; Fahmi H; Laufer S; Reboul P; Boileau C; Lavigne M; Pelletier JP
Arthritis Rheum; 2004 Dec; 50(12):3925-33. PubMed ID: 15593193
[TBL] [Abstract][Full Text] [Related]
14. Effects of arachidonic acid, docosahexaenoic acid, prostaglandin E(2) and parathyroid hormone on osteoprotegerin and RANKL secretion by MC3T3-E1 osteoblast-like cells.
Coetzee M; Haag M; Kruger MC
J Nutr Biochem; 2007 Jan; 18(1):54-63. PubMed ID: 16650751
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of COX-2 by celecoxib in the canine groove model of osteoarthritis.
Mastbergen SC; Marijnissen AC; Vianen ME; Zoer B; van Roermund PM; Bijlsma JW; Lafeber FP
Rheumatology (Oxford); 2006 Apr; 45(4):405-13. PubMed ID: 16287921
[TBL] [Abstract][Full Text] [Related]
16. IL-1beta stimulates the expression of prostaglandin receptor EP4 in human chondrocytes by increasing production of prostaglandin E2.
Watanabe Y; Namba A; Honda K; Aida Y; Matsumura H; Shimizu O; Suzuki N; Tanabe N; Maeno M
Connect Tissue Res; 2009; 50(3):186-93. PubMed ID: 19444759
[TBL] [Abstract][Full Text] [Related]
17. Long term NSAID treatment inhibits COX-2 synthesis in the knee synovial membrane of patients with osteoarthritis: differential proinflammatory cytokine profile between celecoxib and aceclofenac.
Alvarez-Soria MA; Largo R; Santillana J; Sánchez-Pernaute O; Calvo E; Hernández M; Egido J; Herrero-Beaumont G
Ann Rheum Dis; 2006 Aug; 65(8):998-1005. PubMed ID: 16476713
[TBL] [Abstract][Full Text] [Related]
18. Modulation of OPG, RANK and RANKL by human chondrocytes and their implication during osteoarthritis.
Kwan Tat S; Amiable N; Pelletier JP; Boileau C; Lajeunesse D; Duval N; Martel-Pelletier J
Rheumatology (Oxford); 2009 Dec; 48(12):1482-90. PubMed ID: 19762475
[TBL] [Abstract][Full Text] [Related]
19. Compressive force induces osteoclast differentiation via prostaglandin E(2) production in MC3T3-E1 cells.
Sanuki R; Shionome C; Kuwabara A; Mitsui N; Koyama Y; Suzuki N; Zhang F; Shimizu N; Maeno M
Connect Tissue Res; 2010 Apr; 51(2):150-8. PubMed ID: 20001844
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E2 exerts catabolic effects in osteoarthritis cartilage: evidence for signaling via the EP4 receptor.
Attur M; Al-Mussawir HE; Patel J; Kitay A; Dave M; Palmer G; Pillinger MH; Abramson SB
J Immunol; 2008 Oct; 181(7):5082-8. PubMed ID: 18802112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
